Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Katsikis, I., Karkanaki A., Misichronis G., Delkos D., Kandaraki E. A., & Panidis D. (2011).  Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.. Eur J Obstet Gynecol Reprod Biol. 156(2), 181-5.
Koiou, E., Dinas K., Tziomalos K., Toulis K., Kandaraki E. A., Kalaitzakis E., et al. (2011).  The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteria.. Obes Facts. 4(2), 145-50.
Papadaniil, C. D., Kosmidou V. E., Tsolaki A., Tsolaki M., Kompatsiaris I. Yiannis, & Hadjileontiadis L. J. (2015).  Phase-amplitude cross-frequency coupling in EEG-derived cortical time series upon an auditory perception task.. Conf Proc IEEE Eng Med Biol Soc. 2015, 4150-3.
Crown, J. P., Diéras V., Staroslawska E., Yardley D. A., Bachelot T., Davidson N., et al. (2013).  Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.. J Clin Oncol. 31(23), 2870-8.
Molife, L. R., Attard G., Fong P. C., Karavasilis V., Reid A. H. M., Patterson S., et al. (2010).  Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC).. Ann Oncol. 21(1), 109-13.
Argiris, A., Karamouzis M. V., Gooding W. E., Branstetter B. F., Zhong S., Raez L. E., et al. (2011).  Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer.. J Clin Oncol. 29(9), 1140-5.
Fountzilas, G., Fragkoulidi A., Kalogera-Fountzila A., Nikolaidou M., Bobos M., Calderaro J., et al. (2010).  A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer.. Cancer Chemother Pharmacol. 65(4), 649-60.
Escudier, B., Roigas J., Gillessen S., Harmenberg U., Srinivas S., Mulder S. F., et al. (2009).  Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.. J Clin Oncol. 27(25), 4068-75.
Papaxoinis, G., Kotoula V., Giannoulatou E., Koliou G-A., Karavasilis V., Lakis S., et al. (2018).  Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.. Med Oncol. 35(7), 101.
Razis, E., Selviaridis P., Labropoulos S., Norris J. L., Zhu M-J., Song D. D., et al. (2009).  Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.. Clin Cancer Res. 15(19), 6258-66.
Briasoulis, E., Golfinopoulos V., Karina M., Papakostas P., Pavlidis N., & Fountzilas G. (2010).  Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study.. Anticancer Drugs. 21(8), 785-9.
Argiris, A., Karamouzis M. V., Smith R., Kotsakis A., Gibson M. K., Lai S. Y., et al. (2011).  Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer.. Ann Oncol. 22(11), 2482-8.
Iliopoulou, E. G., Kountourakis P., Karamouzis M. V., Doufexis D., Ardavanis A., Baxevanis C. N., et al. (2010).  A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.. Cancer Immunol Immunother. 59(12), 1781-9.
Karavasilis, V., Kotoula V., Pentheroudakis G., Televantou D., Lambaki S., Chrisafi S., et al. (2013).  A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.. J Neurol. 260(6), 1469-80.
M Cappellini, D., Viprakasit V., Taher A. T., Georgiev P., Kuo K. H. M., Coates T., et al. (2020).  A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.. N Engl J Med. 382(13), 1219-1231.
Gavriatopoulou, M., Kastritis E., Kyrtsonis M-C., Vassilakopoulos T. P., Roussou M., Fotiou D., et al. (2017).  Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.. Leuk Lymphoma. 58(6), 1506-1508.
Athyros, V. G., & Mikhailidis D. P. (2012).  Pharmacotherapy: statins and new-onset diabetes mellitus--a matter for debate.. Nat Rev Endocrinol. 8(3), 133-4.
Upadhyay, J., Polyzos S. A., Perakakis N., Thakkar B., Paschou S. A., Katsiki N., et al. (2018).  Pharmacotherapy of type 2 diabetes: An update.. Metabolism. 78, 13-42.
Pilitsi, E., Farr O. M., Polyzos S. A., Perakakis N., Nolen-Doerr E., Papathanasiou A-E., et al. (2019).  Pharmacotherapy of obesity: Available medications and drugs under investigation.. Metabolism. 92, 170-192.
Loutradis, C., & Sarafidis P. (2020).  Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease.. Expert Opin Pharmacother. 21(10), 1201-1217.
Pompili, M., Innamorati M., Gonda X., Serafini G., Erbuto D., Ricci F., et al. (2014).  Pharmacotherapy in bipolar disorders during hospitalization and at discharge predicts clinical and psychosocial functioning at follow-up.. Hum Psychopharmacol. 29(6), 578-88.
Hatzimouratidis, K., Salonia A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., et al. (2016).  Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 13(4), 465-88.
Eardley, I., Donatucci C., Corbin J., El-Meliegy A., Hatzimouratidis K., McVary K., et al. (2010).  Pharmacotherapy for erectile dysfunction.. J Sex Med. 7(1 Pt 2), 524-40.
Kalinderi, K., Fidani L., Katsarou Z., & Bostantjopoulou S. (2011).  Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.. Int J Clin Pract. 65(12), 1289-94.
Ohmasa, F., Saito M., Oiwa H., Tsounapi P., Shomori K., Kitatani K., et al. (2012).  Pharmacological preconditioning of ATP-sensitive potassium channel openers on acute urinary retention-induced bladder dysfunction in the rat.. BJU Int. 110(6 Pt B), E245-52.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές